In Silico Fragment Size Selection for Enhanced Fetal Fraction and Abnormality Origin Discernment Using Pair‐End Sequencing of Maternal Plasma DNA

Documenti analoghi

• Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
  di: Susan Hancock, et al.
  Pubblicazione: (2026)
• Clinical Implications of Noninvasive Prenatal Testing Failures Due to Low Fetal Fraction: Associations With Adverse Maternal and Fetal Outcomes
  di: Yuan Ren, et al.
  Pubblicazione: (2025)
• Gasdermin D‐Mediated Release of IL‐33 Results in Fetal Brain Developmental Abnormalities During Maternal Colitis
  di: Huiyang Jia, et al.
  Pubblicazione: (2026)
• Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease
  di: Chrystalle Katte Carreon, et al.
  Pubblicazione: (2024)
• Genetic Abnormalities and Clinical Management of Fetal Genitourinary System Anomalies in Eastern China
  di: Jie Liang, et al.
  Pubblicazione: (2026)